You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 9,457,020


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,457,020 protect, and when does it expire?

Patent 9,457,020 protects ALOXI and is included in one NDA.

Protection for ALOXI has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-three patent family members in forty countries.

Summary for Patent: 9,457,020
Title:Liquid pharmaceutical formulations of palonosetron
Abstract: The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron. The formulations are particularly useful in the preparation of intravenous and oral liquid medicaments.
Inventor(s): Calderari; Giorgio (Rancate, CH), Bonadeo; Daniele (Casalzuigno, CH), Cannella; Roberta (Varese, IT), Miksztal; Andrew (Palo Alto, CA), Malefyt; Thomas (Carmel Valley, CA), Lee; Kathleen M (Palo Alto, CA)
Assignee: Helsinn Healthcare SA (Lugano, Pazzallo, CH)
Application Number:14/855,564
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,457,020: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to fully comprehend its implications and validity. This article will provide a detailed analysis of United States Patent 9,457,020, focusing on its claims, scope, and the relevant legal and practical considerations.

Patent Overview

United States Patent 9,457,020, like any other patent, is a grant of a property right by the Government to the inventor(s) or their heirs and assigns for a limited time in exchange for public disclosure of the invention. The patent document includes a detailed description of the invention, drawings, and claims that define the scope of the invention.

Claims Analysis

Independent and Dependent Claims

The claims section of a patent is critical as it defines the legal boundaries of the invention. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim or another dependent claim[4].

  • Independent Claims: These claims are essential as they set the broadest scope of what the inventor is claiming as their invention. For example, if a patent has multiple independent claims, each claim may cover different aspects or embodiments of the invention.
  • Dependent Claims: These claims narrow down the scope of the independent claims by adding additional limitations. They are often used to provide a hierarchy of claims, allowing the patent holder to fall back on narrower claims if the broader claims are challenged.

Claim Language and Scope

The language used in the claims is pivotal in determining the patent's scope. Metrics such as independent claim length and independent claim count can be used to measure patent scope. Generally, longer independent claims and a higher number of independent claims can indicate a broader patent scope, although this may also lead to decreased clarity and increased litigation risks[3].

Patent Scope

Measuring Patent Scope

Patent scope can be measured using various metrics, including:

  • Independent Claim Length: Longer claims often indicate more complex inventions or attempts to cover a broader range of embodiments.
  • Independent Claim Count: A higher number of independent claims can suggest a more comprehensive coverage of the invention.
  • Forward Citations: The number of times a patent is cited by later patents can indicate its impact and scope within the field.
  • Patent Maintenance Payments: The cost and effort to maintain a patent over its term can reflect its scope and importance[3].

Impact on Innovation

The scope of a patent can significantly influence innovation. Broad patents with unclear boundaries can lead to increased licensing and litigation costs, potentially discouraging innovation. Conversely, well-defined and narrower patents can provide clear boundaries, encouraging further innovation by reducing the risk of infringement[3].

Patent Landscape

Family of Patents

A patent can be part of a larger family of patents, including continuations, continuations-in-part, and divisional applications. Each member of the family may have different claims and expiration dates, which can affect the overall patent landscape. For instance, the Cellect case highlights how different patents within the same family can be affected by obviousness-type double patenting (ODP) and Patent Term Adjustments (PTA)[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent. This can be particularly relevant when dealing with a family of patents, as seen in the Cellect case where multiple patents were found to be unpatentable over earlier patents within the same family[1].

Patent Term Adjustments (PTA) and Terminal Disclaimers

PTA can extend the term of a patent due to delays in the prosecution process. However, terminal disclaimers, which are often used to overcome ODP rejections, can limit the extended term. The Cellect case illustrates how PTA and terminal disclaimers interact, emphasizing that a grant of PTA does not extend the term past the date of a terminal disclaimer[1].

Legal and Practical Considerations

Small Claims Patent Court

The concept of a small claims patent court has been explored to address the high costs and complexities associated with patent litigation. Such a court could provide a more accessible and efficient forum for resolving patent disputes, particularly for small inventors and businesses. The Administrative Conference of the United States (ACUS) has conducted studies on the feasibility and structure of such a court, highlighting the need for balanced legal, policy, and practical considerations[2].

Public Input and Stakeholder Engagement

Public input and stakeholder engagement are crucial in shaping patent law and policy. For example, the ACUS study on a small claims patent court involved extensive public comments and input from a wide range of stakeholders, including academic experts and legal practitioners. This ensures that any changes to the patent system are well-informed and address the needs of various stakeholders[2].

Case Studies and Examples

Cellect LLC Case

The Cellect LLC case provides a practical example of how ODP, PTA, and terminal disclaimers can interact within a family of patents. This case highlights the complexities of managing multiple patents with different expiration dates and the importance of careful patent strategy to avoid invalidation due to ODP[1].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the patent.
  • Patent Scope Metrics: Metrics such as independent claim length and count can help measure the breadth of a patent.
  • Patent Landscape: The family of patents, ODP, PTA, and terminal disclaimers can significantly affect the patent's validity and term.
  • Legal and Practical Considerations: Small claims patent courts and public input are important for addressing the complexities and costs associated with patent litigation.

FAQs

Q: What is the significance of independent claims in a patent? A: Independent claims define the broadest scope of the invention and stand alone without reference to other claims.

Q: How does obviousness-type double patenting (ODP) affect patents? A: ODP prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent.

Q: What is the purpose of Patent Term Adjustments (PTA)? A: PTA extends the term of a patent due to delays in the prosecution process caused by the USPTO.

Q: Why is public input important in patent law and policy? A: Public input ensures that changes to the patent system are well-informed and address the needs of various stakeholders.

Q: What is the proposed role of a small claims patent court? A: A small claims patent court aims to provide a more accessible and efficient forum for resolving patent disputes, particularly for small inventors and businesses.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2]
  3. Patent Claims and Patent Scope - SSRN[3]
  4. Patent Law in the United States - BitLaw[4]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,457,020

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Helsinn Hlthcare ALOXI palonosetron hydrochloride INJECTABLE;INTRAVENOUS 021372-002 Feb 29, 2008 DISCN Yes No 9,457,020*PED ⤷  Subscribe Y ⤷  Subscribe
Helsinn Hlthcare ALOXI palonosetron hydrochloride INJECTABLE;INTRAVENOUS 021372-001 Jul 25, 2003 DISCN Yes No 9,457,020*PED ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,457,020

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 2110 ⤷  Subscribe
Argentina 042977 ⤷  Subscribe
Austria 410167 ⤷  Subscribe
Australia 2004208505 ⤷  Subscribe
Brazil PI0407121 ⤷  Subscribe
Canada 2514224 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.